Real-Life Analysis of Therapeutic Management and Its Correlation With the Dermatology Life Quality Index Score in 108 Patients With Pustular Psoriasis: An Italian Monocenter Study

Introduction: Pustular psoriasis (PP) is a rare life-threatening skin disease with negatively impact on quality of life (QoL). Clinically, it may be systemic (generalized pustular psoriasis [GPP]) or localized on palms and soles (palmoplantar pustulosis [PPP]). It is not rare to observe plaque psor...

Full description

Saved in:
Bibliographic Details
Main Authors: Dario Buononato, Emanuele Scala, Pierfrancesco Benvenuto, Stefano Caccavale, Eugenia Veronica Di Brizzi, Roberta Di Caprio, Giuseppe Argenziano, Anna Balato
Format: Article
Language:English
Published: Mattioli1885 2025-01-01
Series:Dermatology Practical & Conceptual
Subjects:
Online Access:https://dpcj.org/index.php/dpc/article/view/4871
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832540719166783488
author Dario Buononato
Emanuele Scala
Pierfrancesco Benvenuto
Stefano Caccavale
Eugenia Veronica Di Brizzi
Roberta Di Caprio
Giuseppe Argenziano
Anna Balato
author_facet Dario Buononato
Emanuele Scala
Pierfrancesco Benvenuto
Stefano Caccavale
Eugenia Veronica Di Brizzi
Roberta Di Caprio
Giuseppe Argenziano
Anna Balato
author_sort Dario Buononato
collection DOAJ
description Introduction: Pustular psoriasis (PP) is a rare life-threatening skin disease with negatively impact on quality of life (QoL). Clinically, it may be systemic (generalized pustular psoriasis [GPP]) or localized on palms and soles (palmoplantar pustulosis [PPP]). It is not rare to observe plaque psoriasis associated with GPP. Objective: We explored the therapies used for PP and their correlation with patient QoL scores, through a cross-sectional study using retrospective data from a monocentric database in the period 2017-2021. Method: Patient characteristics were summarized using descriptive statistics and treatment predictors of QoL were identified by multiple regression analysis. Among 108 patients with PP, 57.4% had GPP + PSO whereas 42.6% had PPP. The therapeutic management is based on systemic conventional treatments and biological therapies in both GPP and PPP. Results: GPP + PSO patients with an impaired QoL (DLQI≥10) were associated with biological therapy including certolizumab (OR=2.38), etanercept (OR=2.25), secukinumab (OR=2.03) or ustekinumab (OR=2.79) whereas, PPP patients were positively associated with secukinumab (OR=2.85) or apremilast (OR 4.28, 95%-CI 0.56-9.62). Conclusion: Currently, systemic conventional therapy remains the therapeutic fulcrum of PP management. A great effect on QoL, especially for GPP+PSO, was assessed regardless the ongoing treatment and only newer biologic options were able to somehow positively impact.
format Article
id doaj-art-48c27db7e6f24ff8bbe17476a21bd0fc
institution Kabale University
issn 2160-9381
language English
publishDate 2025-01-01
publisher Mattioli1885
record_format Article
series Dermatology Practical & Conceptual
spelling doaj-art-48c27db7e6f24ff8bbe17476a21bd0fc2025-02-04T15:41:30ZengMattioli1885Dermatology Practical & Conceptual2160-93812025-01-0115110.5826/dpc.1501a4871Real-Life Analysis of Therapeutic Management and Its Correlation With the Dermatology Life Quality Index Score in 108 Patients With Pustular Psoriasis: An Italian Monocenter StudyDario Buononato0Emanuele Scala1Pierfrancesco Benvenuto2Stefano Caccavale3Eugenia Veronica Di Brizzi4Roberta Di Caprio5Giuseppe Argenziano6Anna Balato7 Unit of Dermatology, University of Campania “Luigi Vanvitelli”, Naples, ItalyDivision of Dermatology and Venereology, Department of Medicine Solna, and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden ; Department of Dermatology and Venereology, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, GermanyUniversità degli studi della campania Luigi VanvitelliUniversità degli studi della campania Luigi VanvitelliUniversità degli studi della campania Luigi VanvitelliUniversità degli studi della campania Luigi VanvitelliUniversità degli studi della campania Luigi VanvitelliUniversità degli studi della campania Luigi Vanvitelli Introduction: Pustular psoriasis (PP) is a rare life-threatening skin disease with negatively impact on quality of life (QoL). Clinically, it may be systemic (generalized pustular psoriasis [GPP]) or localized on palms and soles (palmoplantar pustulosis [PPP]). It is not rare to observe plaque psoriasis associated with GPP. Objective: We explored the therapies used for PP and their correlation with patient QoL scores, through a cross-sectional study using retrospective data from a monocentric database in the period 2017-2021. Method: Patient characteristics were summarized using descriptive statistics and treatment predictors of QoL were identified by multiple regression analysis. Among 108 patients with PP, 57.4% had GPP + PSO whereas 42.6% had PPP. The therapeutic management is based on systemic conventional treatments and biological therapies in both GPP and PPP. Results: GPP + PSO patients with an impaired QoL (DLQI≥10) were associated with biological therapy including certolizumab (OR=2.38), etanercept (OR=2.25), secukinumab (OR=2.03) or ustekinumab (OR=2.79) whereas, PPP patients were positively associated with secukinumab (OR=2.85) or apremilast (OR 4.28, 95%-CI 0.56-9.62). Conclusion: Currently, systemic conventional therapy remains the therapeutic fulcrum of PP management. A great effect on QoL, especially for GPP+PSO, was assessed regardless the ongoing treatment and only newer biologic options were able to somehow positively impact. https://dpcj.org/index.php/dpc/article/view/4871generalized pustular psoriasispalmoplantar pustular pustulosisDLQIPsoriasisBiological Therapy
spellingShingle Dario Buononato
Emanuele Scala
Pierfrancesco Benvenuto
Stefano Caccavale
Eugenia Veronica Di Brizzi
Roberta Di Caprio
Giuseppe Argenziano
Anna Balato
Real-Life Analysis of Therapeutic Management and Its Correlation With the Dermatology Life Quality Index Score in 108 Patients With Pustular Psoriasis: An Italian Monocenter Study
Dermatology Practical & Conceptual
generalized pustular psoriasis
palmoplantar pustular pustulosis
DLQI
Psoriasis
Biological Therapy
title Real-Life Analysis of Therapeutic Management and Its Correlation With the Dermatology Life Quality Index Score in 108 Patients With Pustular Psoriasis: An Italian Monocenter Study
title_full Real-Life Analysis of Therapeutic Management and Its Correlation With the Dermatology Life Quality Index Score in 108 Patients With Pustular Psoriasis: An Italian Monocenter Study
title_fullStr Real-Life Analysis of Therapeutic Management and Its Correlation With the Dermatology Life Quality Index Score in 108 Patients With Pustular Psoriasis: An Italian Monocenter Study
title_full_unstemmed Real-Life Analysis of Therapeutic Management and Its Correlation With the Dermatology Life Quality Index Score in 108 Patients With Pustular Psoriasis: An Italian Monocenter Study
title_short Real-Life Analysis of Therapeutic Management and Its Correlation With the Dermatology Life Quality Index Score in 108 Patients With Pustular Psoriasis: An Italian Monocenter Study
title_sort real life analysis of therapeutic management and its correlation with the dermatology life quality index score in 108 patients with pustular psoriasis an italian monocenter study
topic generalized pustular psoriasis
palmoplantar pustular pustulosis
DLQI
Psoriasis
Biological Therapy
url https://dpcj.org/index.php/dpc/article/view/4871
work_keys_str_mv AT dariobuononato reallifeanalysisoftherapeuticmanagementanditscorrelationwiththedermatologylifequalityindexscorein108patientswithpustularpsoriasisanitalianmonocenterstudy
AT emanuelescala reallifeanalysisoftherapeuticmanagementanditscorrelationwiththedermatologylifequalityindexscorein108patientswithpustularpsoriasisanitalianmonocenterstudy
AT pierfrancescobenvenuto reallifeanalysisoftherapeuticmanagementanditscorrelationwiththedermatologylifequalityindexscorein108patientswithpustularpsoriasisanitalianmonocenterstudy
AT stefanocaccavale reallifeanalysisoftherapeuticmanagementanditscorrelationwiththedermatologylifequalityindexscorein108patientswithpustularpsoriasisanitalianmonocenterstudy
AT eugeniaveronicadibrizzi reallifeanalysisoftherapeuticmanagementanditscorrelationwiththedermatologylifequalityindexscorein108patientswithpustularpsoriasisanitalianmonocenterstudy
AT robertadicaprio reallifeanalysisoftherapeuticmanagementanditscorrelationwiththedermatologylifequalityindexscorein108patientswithpustularpsoriasisanitalianmonocenterstudy
AT giuseppeargenziano reallifeanalysisoftherapeuticmanagementanditscorrelationwiththedermatologylifequalityindexscorein108patientswithpustularpsoriasisanitalianmonocenterstudy
AT annabalato reallifeanalysisoftherapeuticmanagementanditscorrelationwiththedermatologylifequalityindexscorein108patientswithpustularpsoriasisanitalianmonocenterstudy